MediciNova, Inc. (MNOV) vs NRx Pharmaceuticals, Inc. (NRXP)
MediciNova, Inc. and NRx Pharmaceuticals, Inc. are both Biotechnology companies. MediciNova, Inc. and NRx Pharmaceuticals, Inc. are of similar size ($132.9M and $131.2M). NRx Pharmaceuticals, Inc. has the higher net margin (−691.8% vs −1,168.3%) and the higher return on invested capital (0.00% vs −62.5%). Across the 15 metrics below, NRx Pharmaceuticals, Inc. leads on 11 and MediciNova, Inc. on 4.
Valuation
Profitability
| Metric | MNOV | NRXP | Biotechnology median |
|---|---|---|---|
| Gross margin | 37.76% | 46.64% | 65.16% |
| Operating margin | (1,287.53%) | (586.15%) | 0.00% |
| Net margin | (1,168.31%) | (691.78%) | 0.00% |
| Free cash flow margin | (991.31%) | (609.02%) | 0.00% |
| Return on equity | (25.56%) | 131.22% | (57.72%) |
| Return on assets | (23.83%) | (120.41%) | (49.22%) |
| Return on invested capital | (62.48%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack